Evaluated articles
A list by Rapid Reviews Infectious Diseases
Articles that have been evaluated by Rapid Reviews COVID-19.
Showing page 32 of 35 pages of list content
-
Tetherin antagonism by SARS‐CoV‐2 ORF3a and spike protein enhances virus release
This article has 15 authors:Reviewed by Review Commons, Rapid Reviews Infectious Diseases, ScreenIT
-
Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile
This article has 16 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial
This article has 29 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers
This article has 31 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Single-Molecule Dynamics of SARS-CoV-2 5’ Cap Recognition by Human eIF4F
This article has 4 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Variants in SARS-CoV-2 associated with mild or severe outcome
This article has 7 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Wastewater surveillance of SARS-CoV-2 across 40 U.S. states from February to June 2020
This article has 22 authors:Reviewed by Rapid Reviews Infectious Diseases
-
Impact of B.1.1.7 variant mutations on antibody recognition of linear SARS-CoV-2 epitopes
This article has 5 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
GRP78 binds SARS-CoV-2 Spike protein and ACE2 and GRP78 depleting antibody blocks viral entry and infection in vitro
This article has 7 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Structural and Functional Comparison of SARS-CoV-2-Spike Receptor Binding Domain Produced in Pichia pastoris and Mammalian Cells
This article has 31 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
-
FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
This article has 12 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations
This article has 12 authors:Reviewed by ScreenIT, Rapid Reviews Infectious Diseases
-
-
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
This article has 24 authors:Reviewed by Rapid Reviews Infectious Diseases, PREreview, ScreenIT
-
-
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
This article has 24 authors:Reviewed by ScreenIT, Rapid Reviews Infectious Diseases
-
Infection fatality rate of COVID-19 inferred from seroprevalence data
This article has 1 author:Reviewed by ScreenIT, Rapid Reviews Infectious Diseases
-
Development of a Codebook of Online Anti-Vaccination Rhetoric to Manage COVID-19 Vaccine Misinformation
This article has 7 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-